Collectively, the results presented here suggest that G007-LK-induced blockade of WNT/β-catenin signaling leads to improved efficacy of PD-1 immune checkpoint blockade, and in addition induction of an IFNγ and CD8+ T cell-dependent anti-tumor-immune response against B16-F10 tumors. The gene discussed is PDCD1; the disease is neoplasm.